CEACAM5 and cancer: In the 90 colorectal cancer patients in this study, the detection sensitivity of CEA increased from 29% to 60% depending on the cancer stage (stage I/II, stage III, and stage IV: 29%, 50%, and 60%, respectively, Figure 2C).